A new global study reveals that an immunotherapy drug called teplizumab can delay the onset of Type 1 diabetes for at least two years in high-risk kids and adults, according to the results of a recent study with 28 research sites. Recently reported in WNDU 16...
Benaroya Research Institute
Category
Autoimmune Disease Advocacy Group Partners with Benaroya Research Institute (BRI)
The MD Coastal Dispatch report that that Operation Shooting Star (OSS), an autoimmune disease Advocacy organization, partnered with a leader in autoimmune disease research, Benaroya Research Institute (BRI) at Virginia Mason.